TrialGastric cancer : official journal of the International Gastric Cancer Association and the Japanese Gastric Cancer Association2024

Bemarituzumab as first-line treatment for locally advanced or metastatic gastric/gastroesophageal junction adenocarcinoma: final analysis of the randomized phase 2 FIGHT trial.

Zev A Wainberg et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.